NeuroOne Medical Technologies Corporation (NMTC) vs Valion Bio, Inc. (VBIO)
A side-by-side comparison of NeuroOne Medical Technologies Corporation and Valion Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NMTC
NeuroOne Medical Technologies Corporation
$1.13HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
VBIO
Valion Bio, Inc.
$2.38HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — NMTC vs VBIO
growth of $100 · dividends reinvested · last 5yNMTC -93.0% (-41.3%/yr)VBIO -100.0% (-89.8%/yr)NMTC compounded faster over this window
Log scale — wide-divergence pair
NMTC VBIO
NMTC vs VBIO: by the numbers
- •VBIO is the larger company ($10M vs $10M market cap).
- •Both run net losses; VBIO's is the smaller (0.00% vs -71.51% net margin).
Metrics side by side
Valuation
| Metric | NMTC | VBIO |
|---|---|---|
| P/S ratio | 0.98 | N/A |
| P/B ratio | 2.61 | 2.32 |
Profitability
| Metric | NMTC | VBIO |
|---|---|---|
| Gross margin | 67.30% | 0.00% |
| Operating margin | -34.94% | 0.00% |
| Net margin | -71.51% | 0.00% |
| ROE | -189.76% | -157.76% |
| ROIC | -183.45% | -55.13% |
Growth (annualized)
| Metric | NMTC | VBIO |
|---|---|---|
| Revenue CAGR (5Y) | 37.21% | N/A |
| Total return CAGR (5Y) | -46.02% | N/A |
Go deeper
Dig into the metrics
NeuroOne Medical Technologies ROEValion Bio ROENeuroOne Medical Technologies operating marginValion Bio operating marginNeuroOne Medical Technologies revenue growthValion Bio revenue growthNeuroOne Medical Technologies free cash flowValion Bio free cash flow
NeuroOne Medical Technologies & Valion Bio appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.